Literature DB >> 31784905

[Screening for temporomandibular disorders : A sensible approach?]

Jens Christoph Türp1, Hans Jürgen Schindler2.   

Abstract

BACKGROUND: Temporomandibular disorders (TMDs) are typically characterized by pain in the masticatory muscles and temporomandibular joints (TMJs) and by limitation of mandibular mobility. In June 2019, the German Society of Craniomandibular Function and Disorders presented a screening tool to identify individuals with TMDs. The assessment tool consists of patient history (three questions related to jaw pain, one question related to impaired mandibular mobility) and a clinical examination (palpation of masticatory muscles and TMJs; evaluation of maximum jaw opening; assessment of the presence of occlusal disturbances; documentation of TMJ noises).
OBJECTIVES: The present article focusses on two questions: (1) Which of the nine parts of the tool are appropriate, and which are not? (2) In general, can screening for TMDs be recommended?
CONCLUSION: While the anamnestic questions, as well as the assessment of maximum mandibular opening, reflect the clinically relevant symptoms and signs of TMD patients, the remaining four clinical measures do not. Furthermore, TMD screening for painful TMDs appears unnecessary because patients suffering from orofacial pain and/or restricted mandibular mobility are likely to consult a therapist by themselves. Therefore, the use of this screening tool may lead to overdiagnosis, possibly resulting in nonindicated diagnostic and therapeutic measures.

Entities:  

Keywords:  Clinical decision-making; Facial pain; Mass screening; Surveys and questionnaires; Temporomandibular joint dysfunction syndrome

Mesh:

Year:  2020        PMID: 31784905     DOI: 10.1007/s00482-019-00432-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  32 in total

1.  Prediction of demand for treatment of temporomandibular disorders.

Authors:  P Kirveskari
Journal:  J Oral Rehabil       Date:  2001-06       Impact factor: 3.837

2.  Severe limitation in jaw movement in a patient with fibrodysplasia ossificans progressiva: a case report.

Authors:  O Faruk Sendur; Gulcan Gurer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-03-20

3.  Assessing clinical signs of temporomandibular disorders: reliability of clinical examiners.

Authors:  S F Dworkin; L LeResche; T DeRouen; M Von Korff
Journal:  J Prosthet Dent       Date:  1990-05       Impact factor: 3.426

4.  A longitudinal epidemiologic study of signs and symptoms of temporomandibular disorders from 15 to 35 years of age.

Authors:  T Magnusson; I Egermark; G E Carlsson
Journal:  J Orofac Pain       Date:  2000

5.  Outcome of three screening questions for temporomandibular disorders (3Q/TMD) on clinical decision-making.

Authors:  A Lövgren; S Marklund; C M Visscher; F Lobbezoo; B Häggman-Henrikson; A Wänman
Journal:  J Oral Rehabil       Date:  2017-05-31       Impact factor: 3.837

6.  Symptoms of temporomandibular disorders in the population: an epidemiological study.

Authors:  Daniela Aparecida de Godoi Gonçalves; Amaury Lélis Dal Fabbro; Juliana Alvares Duarte Bonini Campos; Marcelo E Bigal; José Geraldo Speciali
Journal:  J Orofac Pain       Date:  2010

7.  Validity of three screening questions (3Q/TMD) in relation to the DC/TMD.

Authors:  A Lövgren; C M Visscher; B Häggman-Henrikson; F Lobbezoo; S Marklund; A Wänman
Journal:  J Oral Rehabil       Date:  2016-08-30       Impact factor: 3.837

Review 8.  How does pain affect jaw muscle activity? The Integrated Pain Adaptation Model.

Authors:  C C Peck; G M Murray; T M Gerzina
Journal:  Aust Dent J       Date:  2008-09       Impact factor: 2.291

9.  Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study.

Authors:  Gary D Slade; Eric Bair; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Luda Diatchenko; William Maixner; Charles Knott; Richard Ohrbach
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  Multivariable modeling of phenotypic risk factors for first-onset TMD: the OPPERA prospective cohort study.

Authors:  Eric Bair; Richard Ohrbach; Roger B Fillingim; Joel D Greenspan; Ronald Dubner; Luda Diatchenko; Erika Helgeson; Charles Knott; William Maixner; Gary D Slade
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.